"Esophageal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ESOPHAGUS.
| Descriptor ID |
D004938
|
| MeSH Number(s) |
C04.588.274.476.205 C04.588.443.353 C06.301.371.205 C06.405.117.430 C06.405.249.205
|
| Concept/Terms |
Esophageal Neoplasms- Esophageal Neoplasms
- Esophageal Neoplasm
- Neoplasm, Esophageal
- Esophagus Neoplasm
- Esophagus Neoplasms
- Neoplasm, Esophagus
- Neoplasms, Esophagus
- Neoplasms, Esophageal
Cancer of Esophagus- Cancer of Esophagus
- Cancer of the Esophagus
- Esophagus Cancer
- Cancer, Esophagus
- Cancers, Esophagus
- Esophagus Cancers
- Esophageal Cancer
- Cancer, Esophageal
- Cancers, Esophageal
- Esophageal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Esophageal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Esophageal Neoplasms".
This graph shows the total number of publications written about "Esophageal Neoplasms" by people in this website by year, and whether "Esophageal Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 4 | 0 | 4 |
| 1997 | 3 | 1 | 4 |
| 1998 | 3 | 3 | 6 |
| 1999 | 14 | 3 | 17 |
| 2000 | 8 | 1 | 9 |
| 2001 | 6 | 3 | 9 |
| 2002 | 10 | 4 | 14 |
| 2003 | 19 | 2 | 21 |
| 2004 | 13 | 3 | 16 |
| 2005 | 19 | 5 | 24 |
| 2006 | 28 | 4 | 32 |
| 2007 | 14 | 4 | 18 |
| 2008 | 28 | 2 | 30 |
| 2009 | 17 | 7 | 24 |
| 2010 | 25 | 0 | 25 |
| 2011 | 32 | 2 | 34 |
| 2012 | 29 | 5 | 34 |
| 2013 | 29 | 4 | 33 |
| 2014 | 30 | 3 | 33 |
| 2015 | 36 | 5 | 41 |
| 2016 | 33 | 6 | 39 |
| 2017 | 31 | 1 | 32 |
| 2018 | 32 | 2 | 34 |
| 2019 | 23 | 1 | 24 |
| 2020 | 49 | 3 | 52 |
| 2021 | 42 | 1 | 43 |
| 2022 | 28 | 1 | 29 |
| 2023 | 33 | 1 | 34 |
| 2024 | 23 | 1 | 24 |
| 2025 | 2 | 0 | 2 |
Below are the most recent publications written about "Esophageal Neoplasms" by people in Profiles.
-
Travel to High-Volume Centers and Survival After Esophagectomy for Cancer. JAMA Surg. 2025 Jan 01; 160(1):19-27.
-
Cervical-First Approach in Thoracoscopic Esophagectomy With Intraoperative Nerve Monitoring for an Esophageal Cancer Patient With Aberrant Right Subclavian Artery. Asian J Endosc Surg. 2025 Jan-Dec; 18(1):e70018.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish. J Clin Oncol. 2025 Jan 20; 43(3):339-349.
-
Neoplastic Progression Risk in Females With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data. Clin Gastroenterol Hepatol. 2025 Feb; 23(2):225-235.e8.
-
Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers. Int J Radiat Oncol Biol Phys. 2024 Oct 01; 120(2):309-314.
-
[11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients. Anticancer Res. 2024 Sep; 44(9):3891-3898.
-
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers. Oncologist. 2024 Aug 05; 29(8):672-680.
-
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitors. Oncologist. 2024 Aug 05; 29(8):721-e1088.
-
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment. Anticancer Res. 2024 Aug; 44(8):3397-3407.